Recent studies into retatritide peptide reveal notable potential for treating weight and type diabetes mellitus. The peptide, a dual activator of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide, looks to present greater weight reduction and glycemic control versus existing treatments. Additional research efforts are necessa